Analysis of the Utilization of Oral Hypoglycemic Agents in 34 Hospitals from Wuhan Area during 2011-2013
10.6039/j.issn.1001-0408.2015.26.10
- VernacularTitle:武汉地区34家医院2011－2013年口服降糖药应用分析
- Author:
Jing DING
;
Dong LIU
- Publication Type:Journal Article
- Keywords:
Wuhan area;
Oral hypoglycemic agents;
DDD;
DDDs;
Analysis of drug use
- From:
China Pharmacy
2015;(26):3635-3639
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the utilization and variation tendency of oral hypoglycemic agents in Wuhan area,and to provide reference for drug selection and enterprise production and sale. METHODS:The utilization of oral hypoglycemic agents in 34 hospitals from Wuhan area during 2011-2013 was analyzed statistically in respects of consumption sum,DDDs and DDC etc. RESULTS:The consumption sum and DDDs of oral hypoglycemic agents increased by 20% and 7% respectively year by year. Acarbose had a market share of over 40%. The drug use frequency of metformin ranked the second place only to acarbose. DPP-4 inhibitor had a promising future,with a consumption sum proportion of more than 10%,while the market share of traditional Chi-nese medicine had fallen below 3%. Except for repaglinide,gliclazide,glimepiride,Xiaoke pills,etc.,the selling of other medica-tions are consistent with the user. CONCLUSIONS:The utilization of oral hypoglycemic drugs is basically rational in 34 hospitals from Wuhan area during 2011-2013.
